Vadim Sapiro Net Worth

The estimated Net Worth of Vadim M. Sapiro is at least $6.07 mil dollars as of 23 February 2018. Mr Sapiro owns over 1,400 units of Opgen Inc stock worth over $6,068 and over the last 7 years he sold OPGN stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Sapiro OPGN stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Opgen Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 1,400 units of OPGN stock worth $2,828 on 23 February 2018.

The largest trade he's ever made was exercising 1,400 units of Opgen Inc stock on 23 February 2018 worth over $2,828. On average, Mr trades about 467 units every 0 days since 2018. As of 23 February 2018 he still owns at least 3,004 units of Opgen Inc stock.

You can see the complete history of Mr Sapiro stock trades at the bottom of the page.

Mr. Vadim Sapiro biography

Vadim Sapiro is the Chief Information Officer at Opgen Inc.

How old is Mr Sapiro?

Mr Sapiro is 50, he's been the Chief Information Officer of Opgen Inc since . There are 5 older and 1 younger executives at Opgen Inc. The oldest executive at Opgen Inc is Dr. G. Terrance Walker Ph.D., 62, who is the Sr. VP of R&D.

What's Mr Sapiro's mailing address?

Vadim's mailing address filed with the SEC is C/O OPGEN, INC. 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG, MD, 20878.

Insiders trading at Opgen Inc

Over the last 9 years, insiders at Opgen Inc have traded over $12,018 worth of Opgen Inc stock and bought 4,331,782 units worth $1,198,700 . The most active insiders traders include Evan/ Fa Jones, Capital, Llcjones Evan/ Fa ..., eCapital, Llc J Ven. On average, Opgen Inc executives and independent directors trade stock every 78 days with the average trade being worth of $280,277. The most recent stock trade was executed by Johannes Bacher on 31 March 2023, trading 6,434 units of OPGN stock currently worth $12,997.

What does Opgen Inc do?

opgen, inc. (nasdaq: opgn) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. using our large and ever-growing acuitas lighthouse® knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. today, through our clia-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. our fda-cleared, ivd products rapidly identify pathogens in positive blood cultures.

Complete history of Mr Sapiro stock trades at Opgen Inc

Opgen Inc executives and stock owners

Opgen Inc executives and other stock owners filed with the SEC include:

• Dr. Oliver Schacht Ph.D.,
  CEO, Pres & Director
• Dr. Oliver Schacht,
  CEO, Pres & Director
• Timothy C. Dec,
  CFO & Corp. Sec.
• Johannes Bacher,
  Chief Operating Officer
• Dr. Arne Materna,
  MD & CEO of Ares Genetics GmbH
• Derek Joesting,
  Sr. VP of US Sales
• Albert Weber,
  Chief Financial Officer
• Dr. Achim Plum,
  Special Advisor of Ares Genetics GmbH
• Dr. Andreas Posch,
  Special Advisor of Ares Genetics GmbH
• Christopher D. Emery,
  Chief Commercial Officer for the Americas
• Dr. G. Terrance Walker Ph.D.,
  Sr. VP of R&D
• Faranak Atrzadeh,
  Chief Marketing & Scientific Affairs Officer
• Michael Farmer,
  VP of Marketing
• Vadim Sapiro,
  Chief Information Officer
• & Co., Inc.Merck Sharp & Do...,
  
• Laurence Mc Carthy,
  Director
• Capital, Llc J Ven,
  10% owner
• Misti Ushio,
  Director
• Timothy J.R. Harris,
  Director
• Kevin Krenitsky,
  President
• Brian G Atwood,
  Director
• Timothy C Dec,
  Chief Financial Officer
• Tina Susan Nova,
  Director
• Evan/ Fa Jones,
  Director
• Capital, Llcjones Evan/ Fa ...,
  Chairman and CEOChief Executive Officer
• Vadim M. Sapiro,
  Chief Information Officer
• R Don Elsey,
  Director
• Matthew Charles Mc Murdo,
  Director
• David Natan,
  Director
• Avraham Ben Tzvi,
  Director
• Mario Crovetto,
  Director
• Johannes Bacher,
  Chief Operating Officer
• Prabhavathi Fernandes,
  Director
• William E. Rhodes,
  Director
• Oliver Schacht,
  Chief Executive Officer
• Albert Weber,
  Chief Finanical Officer
• Yvonne Schlaeppi,
  Director
• David E. Lazar,
  Chief Executive Officer